Artwork
iconShare
 
Manage episode 411747289 series 3344953
Content provided by Justin Loizos. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Justin Loizos or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

In this episode of The Just M.S. Show, host Justin Loizos brings you the latest news from the frontlines of medical research, focusing on neuromyelitis optica spectrum disorder (NMOSD). He discusses the exciting results from the Phase 3 CHAMPION-NMOSD trial, led by Dr. Sean Pittock of the Mayo Clinic. The trial, which studied a promising new treatment called ravulizumab, yielded incredible results. Over a 74-week follow-up period, no clinical relapses were observed, representing a risk reduction of 98.6%. Tune in to hear more about this groundbreaking research and its implications for the NMOSD and MS warrior community.
https://www.neurologylive.com/view/success-ravulizumab-through-phase-3-champion-nmosd-trial-sean-pittock

The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com

  continue reading

62 episodes